| Title: |
CRISPR-Cas13d Exhibits Robust Antiviral Activity Against Seneca Valley Virus. |
| Authors: |
Zhang, Yu-Yuan, Sun, Ming-Xia, Lian, Yuexiao, Wang, Tong-Yun, Jia, Mei-Yu, Leng, Chaoliang, Chen, Meng, Bai, Yuan-Zhe, Meng, Fandan, Cai, Xue-Hui, Tang, Yan-Dong |
| Source: |
Frontiers in Microbiology; 2/14/2022, Vol. 13, p1-6, 6p |
| Subject Terms: |
ANTIVIRAL agents, INFECTIOUS disease transmission, SWINE industry, ACTINOBACILLUS pleuropneumoniae, VIRUSES, INFECTION control, EPIDEMICS |
| Abstract: |
In recent years, Seneca Valley virus (SVV) as a newly identified pathogen of porcine vesicular disease spread quickly and has posed a potential threat to the swine industry in several countries resulting in economic losses. Considering the evolution of SVV, attention should be given to controlling SVV epidemics. So far there are no commercial vaccines or drugs available to combat SVV. Therefore, development of strategies for preventing and controlling SVV infection should be taken into account. In the current study, we evaluated whether the CRISPR-Cas13d system could be used as a powerful tool against SVV infection. Besides, selected crRNAs showed different capacity against SVV infection. Our study suggests the CRISPR-Cas13d system significantly inhibited SVV replication and exhibited potent anti-SVV activity. This knowledge may provide a novel alternative strategy to control epidemics of SVV in the future. [ABSTRACT FROM AUTHOR] |
|
Copyright of Frontiers in Microbiology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
